TY  - GEN
AU  - Ciurea,S O
AU  - Saliba,R
AU  - Rondon,G
AU  - Pesoa,S
AU  - Cano,P
AU  - Fernandez-Vina,M
AU  - Qureshi,S
AU  - Worth,L L
AU  - McMannis,J
AU  - Kebriaei,P
AU  - Jones,R B
AU  - Korbling,M
AU  - Qazilbash,M
AU  - Shpall,E J
AU  - Giralt,S
AU  - de Lima,M
AU  - Champlin,R E
AU  - Gajewski,J
TI  - Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT
SN  - 1476-5365
PY  - 2010///0603
KW  - Adolescent
KW  - Adult
KW  - Antilymphocyte Serum
KW  - administration & dosage
KW  - Child
KW  - Female
KW  - Hematologic Neoplasms
KW  - therapy
KW  - Hematopoietic Stem Cell Transplantation
KW  - adverse effects
KW  - Humans
KW  - Infections
KW  - etiology
KW  - Leukemia, Myeloid, Acute
KW  - Male
KW  - Melphalan
KW  - Middle Aged
KW  - Myeloablative Agonists
KW  - Myelodysplastic Syndromes
KW  - Survival Rate
KW  - T-Lymphocytes
KW  - immunology
KW  - Thiotepa
KW  - Transplantation Conditioning
KW  - methods
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Vidarabine
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1038/bmt.2009.189
ER  -